{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T02:46:55Z","timestamp":1777517215222,"version":"3.51.4"},"reference-count":40,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2019,3,28]],"date-time":"2019-03-28T00:00:00Z","timestamp":1553731200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006012","name":"Christian Doppler Forschungsgesellschaft","doi-asserted-by":"publisher","award":["CDL-MSRPD"],"award-info":[{"award-number":["CDL-MSRPD"]}],"id":[{"id":"10.13039\/501100006012","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["P26967-B20"],"award-info":[{"award-number":["P26967-B20"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0214332","type":"journal-article","created":{"date-parts":[[2019,3,28]],"date-time":"2019-03-28T13:49:37Z","timestamp":1553780977000},"page":"e0214332","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":11,"title":["A systems pharmacology workflow with experimental validation to assess the potential of anakinra for treatment of focal and segmental glomerulosclerosis"],"prefix":"10.1371","volume":"14","author":[{"given":"Michael","family":"Boehm","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva Nora","family":"Bukosza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Huttary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Herzog","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Aufricht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0803-614X","authenticated-orcid":true,"given":"Klaus","family":"Kratochwill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph A.","family":"Gebeshuber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2019,3,28]]},"reference":[{"issue":"3","key":"ref1","doi-asserted-by":"crossref","first-page":"502","DOI":"10.2215\/CJN.05960616","article-title":"Focal Segmental Glomerulosclerosis","volume":"12","author":"A.Z. Rosenberg","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"ref2","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1053\/snep.2003.50012","article-title":"Pathologic classification of focal segmental glomerulosclerosis","volume":"23","author":"V. D'Agati","year":"2003","journal-title":"Semin Nephrol"},{"issue":"3","key":"ref3","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1053\/j.ajkd.2017.09.025","article-title":"Mortality and Allograft Loss Trends Among US Pediatric Kidney Transplant Recipients With and Without Focal Segmental Glomerulosclerosis","volume":"71","author":"C.S. Wang","year":"2018","journal-title":"Am J Kidney Dis"},{"issue":"10","key":"ref4","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1681\/ASN.2016101121","article-title":"Long-Term Outcome of Steroid-Resistant Nephrotic Syndrome in Children","volume":"28","author":"A. Trautmann","year":"2017","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"ref5","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1080\/13543784.2017.1351544","article-title":"Investigational drugs in development for focal segmental glomerulosclerosis","volume":"26","author":"H. Trachtman","year":"2017","journal-title":"Expert Opin Investig Drugs"},{"issue":"10","key":"ref6","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1007\/s00467-017-3780-7","article-title":"Difficult-to-treat idiopathic nephrotic syndrome: established drugs, open questions and future options","volume":"33","author":"M.J. Kemper","year":"2018","journal-title":"Pediatr Nephrol"},{"issue":"11","key":"ref7","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1097\/01.smj.0000243183.87381.c2","article-title":"Minimal change disease: a review","volume":"99","author":"T.C. Saha","year":"2006","journal-title":"South Med J"},{"key":"ref8","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.7300.1","article-title":"Cell biology and genetics of minimal change disease","volume":"5","author":"M.A. Saleem","year":"2016","journal-title":"F1000Res"},{"issue":"2","key":"ref9","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/ki.1997.346","article-title":"Podocytes are the major source of IL-1 alpha and IL-1 beta in human glomerulonephritides","volume":"52","author":"Z.I. Niemir","year":"1997","journal-title":"Kidney Int"},{"key":"ref10"},{"key":"ref11","unstructured":"Specialised-Commissioning-Team. <italic>Clinical Commissioning Policy: Anakinra to treat periodic fevers and autoinflammatory diseases (all ages)<\/italic>. 2018 22.10.2018]; Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.england.nhs.uk\/wp-content\/uploads\/2018\/07\/1713-anakinra-for-periodic-fever.pdf\" xlink:type=\"simple\">https:\/\/www.england.nhs.uk\/wp-content\/uploads\/2018\/07\/1713-anakinra-for-periodic-fever.pdf<\/ext-link>."},{"issue":"11","key":"ref12","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1007\/s40265-018-0942-2","article-title":"The Future of IL-1 Targeting in Kidney Disease","volume":"78","author":"B. Afsar","year":"2018","journal-title":"Drugs"},{"issue":"9","key":"ref13","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1007\/s00467-007-0500-8","article-title":"A variant Muckle-Wells syndrome with a novel mutation in CIAS1 gene responding to anakinra","volume":"22","author":"B. Dalgic","year":"2007","journal-title":"Pediatr Nephrol"},{"issue":"4","key":"ref14","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s00467-015-3249-5","article-title":"Anti-interleukin 1 treatment in secondary amyloidosis associated with autoinflammatory diseases","volume":"31","author":"R. Topaloglu","year":"2016","journal-title":"Pediatr Nephrol"},{"issue":"7","key":"ref15","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1002\/acr.23446","article-title":"Nationwide Experience With Off-Label Use of Interleukin-1 Targeting Treatment in Familial Mediterranean Fever Patients","volume":"70","author":"S. Akar","year":"2018","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"6","key":"ref16","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.kint.2015.12.058","article-title":"Drug discovery in focal and segmental glomerulosclerosis","volume":"89","author":"N. Pullen","year":"2016","journal-title":"Kidney Int"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.kint.2017.12.026","article-title":"Drug repurposing in kidney disease","volume":"94","author":"U. Panchapakesan","year":"2018","journal-title":"Kidney Int"},{"issue":"1","key":"ref18","doi-asserted-by":"crossref","first-page":"e0169518","DOI":"10.1371\/journal.pone.0169518","article-title":"Positioning of Tacrolimus for the Treatment of Diabetic Nephropathy Based on Computational Network Analysis","volume":"12","author":"C. Aschauer","year":"2017","journal-title":"PLoS One"},{"issue":"12","key":"ref19","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1007\/s00125-016-4032-2","article-title":"Using systems biology to evaluate targets and mechanism of action of drugs for diabetes comorbidities","volume":"59","author":"B. Mayer","year":"2016","journal-title":"Diabetologia"},{"issue":"Suppl 4","key":"ref20","doi-asserted-by":"crossref","first-page":"iv105-112","DOI":"10.1093\/ndt\/gfv210","article-title":"Drugs meeting the molecular basis of diabetic kidney disease: bridging from molecular mechanism to personalized medicine","volume":"30","author":"H.J. Lambers Heerspink","year":"2015","journal-title":"Nephrol Dial Transplant"},{"issue":"11","key":"ref21","doi-asserted-by":"crossref","first-page":"3995","DOI":"10.1093\/ndt\/gfs489","article-title":"Systems biology: building a useful model from multiple markers and profiles","volume":"27","author":"P. Mayer","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3389\/fcell.2014.00037","article-title":"From molecular signatures to predictive biomarkers: modeling disease pathophysiology and drug mechanism of action.","volume":"2","author":"A. Heinzel","year":"2014","journal-title":"Front Cell Dev Biol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/978-1-4939-0709-0_7","article-title":"Functional molecular units for guiding biomarker panel design","volume":"1159","author":"A. Heinzel","year":"2014","journal-title":"Methods Mol Biol"},{"issue":"1","key":"ref24","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2105-4-2","article-title":"An automated method for finding molecular complexes in large protein interaction networks","volume":"4","author":"G.D. Bader","year":"2003","journal-title":"BMC Bioinformatics"},{"issue":"6","key":"ref25","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1038\/ki.2012.487","article-title":"Molecular fingerprinting of the podocyte reveals novel gene and protein regulatory networks","volume":"83","author":"M. Boerries","year":"2013","journal-title":"Kidney Int"},{"issue":"1","key":"ref26","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1440-1797.2010.01383.x","article-title":"Adriamycin nephropathy: a model of focal segmental glomerulosclerosis","volume":"16","author":"V.W. Lee","year":"2011","journal-title":"Nephrology (Carlton),"},{"issue":"10","key":"ref27","doi-asserted-by":"crossref","first-page":"3476","DOI":"10.1172\/JCI60777","article-title":"IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice","volume":"122","author":"J. Petrasek","year":"2012","journal-title":"J Clin Invest"},{"issue":"3","key":"ref28","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1093\/ndt\/gfr459","article-title":"Alanyl-glutamine dipeptide restores the cytoprotective stress proteome of mesothelial cells exposed to peritoneal dialysis fluids","volume":"27","author":"K. Kratochwill","year":"2012","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"ref29","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1038\/s41467-018-05116-5","article-title":"Network-based approach to prediction and population-based validation of in silico drug repurposing","volume":"9","author":"F. Cheng","year":"2018","journal-title":"Nat Commun"},{"issue":"8","key":"ref30","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/nm.2411","article-title":"Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis","volume":"17","author":"C. Wei","year":"2011","journal-title":"Nat Med"},{"issue":"7","key":"ref31","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1007\/s00467-013-2452-5","article-title":"Serum suPAR in patients with FSGS: trash or treasure?","volume":"28","author":"R.J. Maas","year":"2013","journal-title":"Pediatr Nephrol"},{"issue":"12","key":"ref32","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1007\/s00467-011-1897-7","article-title":"Distinct metalloproteinase excretion patterns in focal segmental glomerulosclerosis","volume":"26","author":"K.A. Czech","year":"2011","journal-title":"Pediatr Nephrol"},{"issue":"1\u20132","key":"ref33","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11010-005-9005-6","article-title":"Increase in extracellular cross-linking by tissue transglutaminase and reduction in expression of MMP-9 contribute differentially to focal segmental glomerulosclerosis in rats","volume":"284","author":"S. Liu","year":"2006","journal-title":"Mol Cell Biochem"},{"issue":"2","key":"ref34","first-page":"311","article-title":"Urokinase-type plasminogen activator, receptor, and inhibitor correlating with gelatinase-B (MMP-9) contribute to inflammation in gouty arthritis of the knee","volume":"33","author":"S.C. Chu","year":"2006","journal-title":"J Rheumatol"},{"issue":"4","key":"ref35","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.2353\/ajpath.2010.090746","article-title":"A molecular profile of focal segmental glomerulosclerosis from formalin-fixed, paraffin-embedded tissue","volume":"177","author":"J.B. Hodgin","year":"2010","journal-title":"Am J Pathol"},{"issue":"3","key":"ref36","doi-asserted-by":"crossref","first-page":"e91559","DOI":"10.1371\/journal.pone.0091559","article-title":"Interleukin-1beta attenuates myofibroblast formation and extracellular matrix production in dermal and lung fibroblasts exposed to transforming growth factor-beta1","volume":"9","author":"M.M. Mia","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"ref37","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1210\/endo.139.3.5818","article-title":"Regulation of matrix metalloproteinases (MMP-2, -3, -9, and -13) by interleukin-1 and interleukin-6 in mouse calvaria: association of MMP induction with bone resorption","volume":"139","author":"K. Kusano","year":"1998","journal-title":"Endocrinology"},{"issue":"6","key":"ref38","first-page":"1117","article-title":"IL-1 receptor antagonist attenuates MAP kinase\/AP-1 activation and MMP1 expression in UVA-irradiated human fibroblasts induced by culture medium from UVB-irradiated human skin keratinocytes","volume":"16","author":"X. Wang","year":"2005","journal-title":"Int J Mol Med"},{"issue":"2","key":"ref39","doi-asserted-by":"crossref","first-page":"F213","DOI":"10.1152\/ajprenal.90421.2008","article-title":"Inducible rodent models of acquired podocyte diseases","volume":"296","author":"J.W. Pippin","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"issue":"10","key":"ref40","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1172\/JCI20402","article-title":"Induction of B7-1 in podocytes is associated with nephrotic syndrome","volume":"113","author":"J. Reiser","year":"2004","journal-title":"J Clin Invest"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0214332","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T19:35:27Z","timestamp":1588966527000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0214332"}},"subtitle":[],"editor":[{"given":"Rajendra","family":"Bhimma","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2019,3,28]]},"references-count":40,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2019,3,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0214332","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,28]]}}}